Try our beta test site
46 studies found for:    Open Studies | "Helicobacter Infections"
Show Display Options
Rank Status Study
21 Recruiting Development of Treatment Algorithm for Eradication of Helicobacter Pylori Based on Antibiotic Susceptibility Test
Condition: Helicobacter Pylori Infection
Intervention: Drug: eradication of Helicobacter pylori
22 Not yet recruiting The Effect of Miswak Chewing Sticks on the Oral Helicobacter Pylori Infection
Conditions: Caries;   Periodontitis
Intervention: Biological: Oral hygiene with Miswak
23 Recruiting Helicobacter Pylori Eradication for Gastric Cancer Prevention in the General Population
Conditions: Gastric Cancer;   Helicobacter Pylori Infection
Interventions: Drug: 10-day bismuth-based quadruple therapy;   Other: Placebo
24 Recruiting Comparison of the Eradications Rates of Sequential Therapy Versus Concomitant Therapy
Condition: Helicobacter Pylori Infection
Interventions: Drug: Sequential therapy 10 days;   Drug: Sequential therapy 14 days;   Drug: Concomitant therapy 10 days;   Drug: Concomitant therapy 14 days
25 Not yet recruiting A Multi-center Study for Individual Treatment of Helicobacter Pylori Infection
Conditions: Gastritis;   Gastric Ulcer
Interventions: Biological: Antibiotic selection based on the antibiotic susceptibility testing;   Genetic: PPI selection based on the CYP2C19 gene polymorphism;   Dietary Supplement: Probiotics usage based on the 16SrRNA sequencing
26 Not yet recruiting Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori Infection
Condition: Duodenal Ulcer
Interventions: Drug: TAK-438;   Drug: Lansoprazole;   Drug: TAK-438 Placebo;   Drug: Lansoprazole Placebo;   Drug: Bismuth-Containing Quadruple Therapy
27 Recruiting Diagnosis Ability of Linked Color Imaging for Helicobacter Pylori Infection Compared With White Light Imaging
Condition: Helicobacter Pylori Infection
Intervention: Other: Esophagogastroduodenoscopy
28 Not yet recruiting 10-day Versus 14-day Concomitant PAMC as First-line Treatment Strategy for the Eradication of H. Pylori Infection
Condition: Helicobacter Pylori Infection
Intervention: Drug: Esomeprazole
29 Not yet recruiting Therapeutic Trial Comparing Triple Therapy Guided by the PCR Detection of Clarithromycin Resistance vs Empiric Concomitant Quadruple Therapy for Helicobacter Pylori Infection
Conditions: H Pylori Infection Eradication;   Antibiotics Therapeutic Strategies;   H Pylori Eradication
Interventions: Other: Quadruple concomitant therapy treatment;   Other: Triple therapy guided by the result of the molecular resistance test
30 Recruiting Personalized Treatment for Refractory H Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: rabeprazole+3 antibiotics;   Drug: rabeprazole+bismuth+2 antibiotics;   Drug: rabeprazole+amox+tetr+levo
31 Recruiting Comparison of Two Rescue Therapies for Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: esomeprazole+amox+levo+tetra;   Drug: esomeprazole+amox+levo
32 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for Rescue Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
33 Recruiting Efficacy of High-dose Dual Therapy vs Bismuth-containing Quadruple Therapy for First-line Treatment of Hp Infection
Condition: Helicobacter Pylori Infection
Interventions: Drug: High-dose dual therapy (rabeprazole, amoxicillin);   Drug: Bismuth-containing quadruple therapy (rabeprazole, tripotassium dicitrate bismuthate, metronidazole, tetracycline)
34 Recruiting European Registry on the Management of Helicobacter Pylori Infection
Condition: H. Pylori Infection
Intervention:
35 Recruiting Triple Therapy Versus Quadruple Therapies in the First Line Therapy of Helicobacter Pylori Infection
Condition: Helicobacter Pylori Infection
Intervention: Drug: triple, quadruple, non-bismuth quadruple therapy
36 Recruiting Multicentric Randomized Study of H. Pylori Eradication and Pepsinogen Testing for Prevention of Gastric Cancer Mortality
Conditions: Helicobacter Pylori Infections;   Atrophic Gastritis;   Gastric Cancer
Intervention: Drug: Triple therapy
37 Recruiting Reinfection After Eradication of Helicobacter Pylori Infection
Conditions: Bacterial Infection Due to Helicobacter Pylori (H. Pylori);   Eradication Therapy of Helicobacter Pylori;   Detection of Helicobacter Pylori
Intervention:
38 Not yet recruiting Potential Adverse Developmental and Nutritional Consequences of Helicobacter Pylori Infection in Israeli Children
Conditions: Helicobacter Pylori Infection;   Iron Deficiency Anemia;   Child Development
Intervention:
39 Not yet recruiting High Dose Dual Therapy (HDDT) for Eradication of Helicobacter Pylori Infection
Condition: Bacterial Infection Due to Helicobacter Pylori (H. Pylori)
Interventions: Drug: Nexium 40 mg;   Drug: amoxicillin 1.5 gr;   Drug: doxycycline 200 mg;   Drug: Nexium 20 mg;   Drug: clarythromicin 500 mg;   Drug: amoxicillin 1gr
40 Recruiting Effect of H. Pylori Eradication on the Reversibility of Atrophic Gastritis and Intestinal Metaplasia in Korean Patients
Conditions: Helicobacter Pylori Infection;   Atrophic Gastritis;   Intestinal Metaplasia
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.